Skip to main content
Triochem Products Ltd. logo

Triochem Products Ltd. — Investor Relations & Filings

Ticker · 512101 ISIN · INE331E01013 BSE.NS Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2024-02-10 Regulatory Filings
Country IN India
Listing BSE.NS 512101

About Triochem Products Ltd.

https://www.triochemproducts.com

Triochem Products Ltd. is a manufacturer and exporter specializing in Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds for the global healthcare and pharmaceutical sectors. Its core product portfolio includes a range of specialized substances such as Quinine salts, Quinidine salts, and other niche therapeutic ingredients. Triochem Products Ltd. emphasizes adherence to stringent quality control measures and international regulatory standards to ensure the efficacy and safety of its chemical outputs. The organization serves a diverse clientele, providing essential raw materials for the formulation of various medications. By leveraging advanced chemical synthesis processes and technical expertise, the company maintains a significant presence in the supply chain for specialized pharmaceutical components.

Recent filings

Filing Released Lang Actions
Extract of newspaper copy of Unaudited Standalone Financial Result for the quarter and nine months ended 31st December 2023 which was duly approved by the Board in its meeting on Friday ....
Regulatory Filings Classification · 95% confidence The document is a letter from Triochem Products Limited addressed to BSE Limited, referencing compliance with Regulation 47 of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. It mentions the publication of an extract of the newspaper containing the Unaudited Standalone Financial Results for the quarter and nine months ended 31st December 2023, which was approved by the Board on 9th February 2024. The document itself is an intimation or announcement about the publication of financial results, not the full financial report or detailed financial statements. The document length is 3068 characters, which is relatively short and consistent with an announcement or intimation rather than a full report. Therefore, this document fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance notice rather than a full Interim/Quarterly Report (IR) or Earnings Release (ER).
2024-02-10 English
The Board of Direcrtors at its meeting held today i.e. 9th February 2024 based on the recommendation of Nomination and Remuneration Committee approved and took on records of the change ....
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to the Bombay Stock Exchange regarding a change in the name of the Company Secretary and Compliance Officer due to marriage. It includes details such as the new name, designation, membership number, and contact information. The document references Regulation 30 of SEBI (LODR) 2015, which pertains to disclosures about changes in key managerial personnel. There is no financial data, report, or presentation included. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2024-02-09 English
The statement of category wise variation is not applicable as there has been no offer made by way of Public Issuem Right Issue, Preferential Issue, etc, during the quarter ended 31st December 2023
Regulatory Filings Classification · 95% confidence The document is a statement submitted to the stock exchange (BSE Limited) regarding deviation or variation in the utilization of funds raised through public issue, rights issue, preferential issue, etc., pursuant to Regulation 32(1) of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015. It specifically mentions it is a statement for the quarter ended 31st December 2023. The document is short (4265 characters) and is a regulatory compliance filing rather than a full financial report. It does not contain financial statements or detailed financial analysis but is a formal disclosure of deviation or variation in fund utilization. This type of document fits best under the category of Regulatory Filings (RNS), as it is a regulatory announcement and does not constitute a full report like an interim or annual report.
2024-02-09 English
Unaudited Standalon Financial Result for the quarter and nine months ended 31st December 2023 duly reviewed by the Audit Committee along with Limited Review Report submitted by the Statutory ....
Regulatory Filings
2024-02-09 English
We would like to inform you that, pursuant to Notice of Board meeting dated 31st January 2024 the Board Meeting of the Company was held today Friday 9th February 2024 at 2.00 p.m. at 4th ....
Regulatory Filings
2024-02-09 English
Notice of Board Meeting dated 9th February 2024 Published in New Paper
Regulatory Filings Classification · 95% confidence The document is a letter from Triochem Products Limited addressed to BSE Limited, referencing compliance with Regulation 47 of SEBI Listing (LODR) Regulations, 2015. It mentions the publication of a Notice of an upcoming Board Meeting scheduled for 9th February 2024, and encloses copies of the Notice published in newspapers. The content is primarily an announcement of a notice related to a Board Meeting, not the meeting materials or minutes themselves. The document length is about 15,000 characters, but the content is focused on informing the stock exchange about the publication of the notice, which is a regulatory compliance announcement. There is no detailed financial data, management discussion, or report content. Therefore, this document fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement related to compliance with listing regulations and notice publication, not a full report or presentation.
2024-02-01 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.